Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Strengthening memory immunity in the aged population by vaccinating
2014-000967-42Phase 4Completed
- Sponsor
- National Institute for Public Health and the Environment
- Start
- May 2014
- Modality
- Vaccines & Immunotherapeutics, Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4 trial of Meningococcal polysaccharide vaccine group W-135 and zoster vaccine, live in meningococcal disease and herpes zoster (HZ), sponsored by National Institute for Public Health and the Environment. Started May 2014; status: completed.
02
Drugs
Meningococcal polysaccharide vaccine group W-135zoster vaccine, live
03
Conditions
meningococcal diseaseherpes zoster (HZ)
Beyond the preview
Go deeper on 2014-000967-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000967-42.